$2.96 +0.17 (%) Idera Pharmaceuticals Inc - NASDAQ

Sep. 2, 2015 | 04:00 PM

Partner Headlines

  1. Mid-Morning Market Update: Markets Open Lower; Carlyle Group To Acquire Blyth For $6/Share

    Benzinga | Aug. 31, 2015 | 10:22AM EST
  2. Idera Pharmaceuticals Announces Appointment of Mark J. Casey as General Counsel and Secretary of the Board of Directors

    Benzinga | Jun. 29, 2015 | 08:32AM EST
  3. Mid-Afternoon Market Update: Standard Pacific Rises On Ryland Merger Deal; Micron Shares Slip

    Benzinga | Jun. 15, 2015 | 15:58PM EST
  4. Mid-Day Market Update: DealerTrack Jumps On Acquisition News; AirMedia Shares Decline

    Benzinga | Jun. 15, 2015 | 14:50PM EST
  5. Morning Market Gainers

    Benzinga | Jun. 15, 2015 | 09:43AM EST
  6. Benzinga's Top Initiations

    Benzinga | Jun. 15, 2015 | 09:10AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 15, 2015 | 08:15AM EST
  8. Idera Pharma Offers Development Update Related to IMO-9200: Pre-Clinical Data Shows Support of Candidate for Oral Therapeutic Option to Treat IBD

    Benzinga | May. 18, 2015 | 08:34AM EST
  9. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  10. Morning Market Losers

    Benzinga | Feb. 10, 2015 | 10:00AM EST
  11. Morning-Market Movers Led By Aeropostale, Coca-Cola & Coupons.Com

    Benzinga | Feb. 10, 2015 | 09:34AM EST
  12. Aeropostale, Idera Pharmaceuticals Lead Monday's After-Hours Movers

    Benzinga | Feb. 9, 2015 | 18:07PM EST
  13. Mid-Morning Market Update: Markets Open Higher; Rite Aid Posts Rise In December Sales

    Benzinga | Jan. 2, 2015 | 11:10AM EST
  14. Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More

    Benzinga | Dec. 30, 2014 | 09:17AM EST
  15. Idera Pharmaceuticals Presents Data Supporting IMO-8400 As Novel Therapy For Genetically Defined Forms Of B-Cell Lymphoma At Annual ASH Meeting

    Benzinga | Dec. 8, 2014 | 17:48PM EST
  16. Mid-Morning Market Update: Markets Open Higher; Cypress To Acquire Spansion In $4 Billion Deal

    Benzinga | Dec. 2, 2014 | 10:26AM EST
  17. US Stock Futures Edge Higher; All Eyes On Jobs Data

    Benzinga | Nov. 7, 2014 | 07:29AM EST
  18. Idera Pharmaceuticals Expands Pipeline By Initiating Clinical Development Of Proprietary TLR Antagonist Candidate IMO-9200

    Benzinga | Oct. 14, 2014 | 08:07AM EST
  19. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down

    Benzinga | May. 13, 2014 | 15:44PM EST
  20. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip

    Benzinga | May. 13, 2014 | 12:40PM EST
  21. Earnings Scheduled For May 13, 2014

    Benzinga | May. 13, 2014 | 04:32AM EST
  22. Idera Expands Management Team with Three Key Hires

    Benzinga | May. 5, 2014 | 08:33AM EST
  23. Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as Markets Hang onto Early Strength

    Benzinga | Apr. 22, 2014 | 16:01PM EST
  24. Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares Slip

    Benzinga | Apr. 22, 2014 | 12:14PM EST
  25. Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness

    Benzinga | Mar. 24, 2014 | 15:33PM EST
  26. Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update

    Benzinga | Mar. 24, 2014 | 12:48PM EST
  27. Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit

    Benzinga | Mar. 24, 2014 | 10:35AM EST
  28. Mid-Afternoon Market Update: 3D Printing Names Take a Hit From Barron's Piece as Fuel Cell Names Continue Rally

    Benzinga | Mar. 10, 2014 | 15:50PM EST
  29. Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares Drop

    Benzinga | Mar. 10, 2014 | 12:44PM EST
  30. Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales Fall 0.3%

    Benzinga | Mar. 10, 2014 | 10:35AM EST
  31. Morning Market Movers

    Benzinga | Oct. 4, 2013 | 10:02AM EST
  32. Morning Market Movers

    Benzinga | Oct. 3, 2013 | 10:02AM EST
  33. Insiders Are Buying Idera Pharmaceuticals

    GuruFocus | Sep. 19, 2013 | 19:33PM EST
  34. Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas

    Benzinga | Aug. 29, 2013 | 08:38AM EST
  35. UPDATE: Piper Jaffray Initiates Idera Pharmaceuticals at Overweight on Encouraging Data

    Benzinga | Jan. 3, 2013 | 05:49AM EST
  36. Benzinga's Top Initiations

    Benzinga | Jan. 3, 2013 | 01:20AM EST
  37. Benzinga's Small Cap Movers for Wednesday December 19, 2012

    Benzinga | Dec. 19, 2012 | 13:25PM EST
  38. Idera Pharmaceuticals Announces Positive Results in Phase 2 Trial of IMO-3100

    Benzinga | Dec. 19, 2012 | 00:03AM EST
  39. Health Care Sector Wrap

    FoxBusiness | Jul. 23, 2012 | 10:47AM EST
  40. Idera Pharmaceuticals Presents Data in Preclinical Models of Lymphoma on IMO-4200, a Dual Agonist of TLRs 7 and 8

    Benzinga | Dec. 13, 2011 | 09:15AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!